Yu Liu

Dr. Yu Liu, with a PhD from Wuhan University and a one-year exchange at Temple University, has solid expertise in tumor immunotherapy and anti-pathogen infection. She has published 7 SCI articles as the first/corresponding author, and has over 4 years experience in R&D of antibody drugs and CAR-T cell drugs at WuXi Biologics and Wuhan Bio-Raid Biotechnology Co., Ltd. This has enabled her to accumulate rich experience ranging from basic research to industrial transformation. She is currently a lecturer of the College of Life Sciences and Health at Wuhan University of Science and Technology.